Natrox: Funding, Investors & Team (Aug 2026)
Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound. NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air and directs it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way.
Natrox has raised $33.0M across 1 funding round on record, the most recent a Series C of $33.0M announced in Dec 2024.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Natrox Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Natrox Funding Rounds
Natrox Founders and Leadership Team
No contact details are on record for this team yet.
Natrox Funding Compared to Other Health Care Startups
Natrox's latest round of $33.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Natrox in Health Care and Cambridge
Companies Similar to Natrox
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Asterix Health is the workforce solution for modern healthcare.
Gloucester Rugby is a professional English rugby union club that gives up to date with all the information…
Natrox Funding FAQs
What does Natrox do?
Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound. NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air and directs it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way.
How much funding has Natrox raised?
Natrox has raised $33.0M across 1 round on record. The most recent is a Series C of $33.0M announced in Dec 2024.
When did Natrox last raise funding?
Natrox's most recent funding round on record is a Series C of $33.0M, announced in Dec 2024.
Who founded Natrox?
FundedIQ lists Mel Vinton (Founder) at Natrox.
Where is Natrox headquartered?
Natrox is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Natrox have?
Natrox is in the 11-50 employee band.
How does Natrox's funding compare to other Health Care startups?
Natrox's latest round of $33.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Natrox Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Natrox is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.